180 related articles for article (PubMed ID: 7787154)
1. Ras oncogene and p53 gene hotspot mutations in colorectal cancers.
Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG
J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154
[TBL] [Abstract][Full Text] [Related]
2. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
6. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
8. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
Xu W; Cheng Y; Shen XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
[TBL] [Abstract][Full Text] [Related]
10. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
[TBL] [Abstract][Full Text] [Related]
11. Using biopsy materials to detect mutations in gastrointestinal tumors.
Hosoi H; Hirosawa S; Yamamoto K; Ohkusa T; Aoki N
J Clin Gastroenterol; 1995 Jun; 20(4):272-6. PubMed ID: 7665812
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
Cancer; 1999 Jul; 86(1):31-6. PubMed ID: 10391560
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
15. Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer.
Palmirotta R; Savonarola A; Ludovici G; De Marchis ML; Covello R; Ettorre GM; Ialongo C; Guadagni F
Folia Histochem Cytobiol; 2011; 49(4):729-33. PubMed ID: 22252770
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
Bühler-Leclerc M; Gratwohl A; Senn HP
Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
[TBL] [Abstract][Full Text] [Related]
17. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
[TBL] [Abstract][Full Text] [Related]
18. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
19. Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer.
Miyakura Y; Sugano K; Fukayama N; Konishi F; Nagai H
Jpn J Clin Oncol; 2002 Jun; 32(6):219-21. PubMed ID: 12110640
[TBL] [Abstract][Full Text] [Related]
20. A double germline mutations in the APC and p53 genes.
Zajac V; Tomka M; Ilenciková D; Májek P; Stevurková V; Kirchhoff T
Neoplasma; 2000; 47(6):335-41. PubMed ID: 11263856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
